Genomic analysis of two rare cases of pediatric Ph-positive T-ALL

被引：0

作者：

Sato-Otsubo, Aiko ^{[1
,2
]}

Osumi, Tomoo ^{[3
]}

Yoshida, Masanori ^{[1
]}

Iguchi, Akihiro ^{[3
,4
]}

Fukushima, Takashi ^{[5
,6
]}

Nakabayashi, Kazuhiko ^{[7
]}

Ogawa, Seishi ^{[8
,9
,10
]}

Hata, Kenichiro ^{[7
]}

Kato, Motohiro ^{[1
,2
,3
]}

机构：

[1] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan

[2] Univ Tokyo, Dept Pediat, Tokyo, Japan

[3] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[4] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan

[5] Saitama Med Univ, Int Med Ctr, Dept Pediat Hematol & Oncol, Saitama, Japan

[6] Univ Tsukuba Hosp, Dept Pediat, Tsukuba, Ibaraki, Japan

[7] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan

[8] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan

[9] Kyoto Univ, Inst Adv Study Human Biol WPI ASHBi, Kyoto, Japan

[10] Karolinska Inst, Dept Mol Hematol, Stockholm, Sweden

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷 / 03期

关键词：

LYMPHOBLASTIC-LEUKEMIA; BCR-ABL1; FUSION; GENE;

D O I：

10.1002/pbc.29427

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[31] Invitation of inactivation of WT1 in pediatric T-ALL
Pisecker, M.
Arzt, L.
Ullmann, R.
Strehl, S.
KLINISCHE PADIATRIE, 2009, 221 (03): : 204 - 204
[32] Integrated Genetic and Epigenetic Analysis in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Kimura, S.
Seki, M.
Kawai, T.
Yoshida, K.
Isobe, T.
Ueno, H.
Suzuki, H.
Oki, K.
Imamura, T.
Kiyokawa, N.
Kobayashi, M.
Koh, K.
Manabe, A.
Ohara, A.
Sanada, M.
Hayashi, Y.
Hata, K.
Miyano, S.
Ogawa, S.
Takita, J.
PEDIATRIC BLOOD & CANCER, 2017, 64 : S31 - S31
[33] Susceptibility of Ph-Positive ALL to TKI Therapy Associated with BCR-ABL Rearrangement Patterns: A Retrospective Analysis
Jing, Yu
Chen, Huiren
Liu, Mingjuan
Zhou, Minhang
Guo, Yuelu
Gao, Chunji
Wang, Quanshun
Li, Honghua
Zhao, Yu
Bo, Jian
Huang, Wenrong
Zhu, Haiyan
Zhang, Yongqing
Yu, Li
PLOS ONE, 2014, 9 (11):
[34] Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive
Yehuda, O
Abeliovich, D
Ben-Neriah, S
Sverdlin, I
Cohen, R
Varadi, G
Orr, R
Ashkenazi, YJ
Heyd, J
Lugassy, G
Ben Yehuda, D
CANCER GENETICS AND CYTOGENETICS, 1999, 114 (02) : 100 - 107
[35] Safety and efficacy of glivec prior to allografting for CML and Ph-positive ALL: European experience
Deininger, MWN
Schleuning, M
Olavarria, E
Fischer, T
Nagler, A
Sayer, H
Boque, C
Volin, L
Piotelli, G
Russel, N
Wandt, H
Schanz, U
Greinix, H
Sponk, L
Sponk
Verdonck, L
Lennard, A
Wimmer, M
Hegenbart, U
Lange, T
Niederwieser, D
BONE MARROW TRANSPLANTATION, 2002, 29 : S31 - S31
[36] Is Initial Dasatinib-Blinatumomab Therapy for Ph-Positive ALL in Adults Cost Effective?
Bitran, Jacob D.
Nabrinsky, Edward
Bufalino, Shams
Knouse, Phillip
Galvez, Angel G.
BLOOD, 2021, 138
[37] TRANSLOCATION T(3-20) ASSOCIATED WITH THROMBOCYTHEMIA IN PH-POSITIVE CML
TURCHINI, MF
TRAVADE, P
DELAROCQUE, A
GENEIX, A
PERISSEL, B
MALET, P
CANCER GENETICS AND CYTOGENETICS, 1986, 20 (1-2) : 1 - 4
[38] Next Generation Genomic Analyses in T-ALL Patients Identify Recurrent and Novel Genomic Abnormalities
Eadie, Laura N.
Rehn, Jacqueline
Heatley, Susan L.
McClure, Barbara J.
Schutz, Caitlin Schutz
Breen, James
Hughes, Timothy P.
Yeung, David T.
Sutton, Rosemary
White, Deborah L.
BLOOD, 2020, 136
[39] Prognostic classification of pediatric T-ALL using oligonucleotide microarrays.
Ferrando, AA
Neuberg, D
Staunton, J
Huard, C
Raimondi, SC
Behm, FG
Downing, JR
Gilliland, DG
Golub, TR
Pui, CH
Lander, ES
Look, AT
BLOOD, 2001, 98 (11) : 759A - 760A
[40] Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration
P J Bhavsar
E Infante
A Khwaja
A J Ridley
Oncogene, 2013, 32 : 198 - 208

← 1 2 3 4 5 →